Dec 29 (Reuters) - Emergent BioSolutions Inc EBS.N :
* EMERGENT BIOSOLUTIONS - ANNOUNCE INITIATION OF CLINICAL PROGRAM TO EVALUATE COVID-19 HUMAN HYPERIMMUNE GLOBULIN PRODUCT CANDIDATE FOR PROPHYLAXIS
Dec 29 (Reuters) - Emergent BioSolutions Inc EBS.N :
* EMERGENT BIOSOLUTIONS - ANNOUNCE INITIATION OF CLINICAL PROGRAM TO EVALUATE COVID-19 HUMAN HYPERIMMUNE GLOBULIN PRODUCT CANDIDATE FOR PROPHYLAXIS